Skip to content
  • 6,688 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started
Menu

Solicitation, total small business set-aside

Center for Biologics Evaluation and Research (CBER) DBPAP/ Amb a 1-Specific Aptamers

75F40124Q00548

Food and Drug Administration, FDA Office of Acq Grant SVCS. Biological Product (except Diagnostic) Manufacturing.

1 open like this View on SAM.gov Markdown

Awarded

Aptagen LLC

$100,000.00 obligated so far on USAspending

Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities

This one was awarded in 2024

1 like it is open now in biological product (except diagnostic) manufacturing

Description

As published on SAM.gov.

PER AMENDMENT 1 - Proposal Receipt date/time extended to 9/27/2024 at 12:00 pm EST.

Introduction Development of Amb a 1- Specific capture and biotin-labeled detection Aptamers for use in Enzyme Linked Immunosorbent Assay (ELISA)/ImmunoEnzymetric Assay (IEMA) Background In the United States ragweed allergen extracts are standardized, which means that their potencies are determined in comparison to a US Reference Standard. Potency of the extract is determined by measuring Amb a 1 content.

The Laboratory of Immunobiochemistry (LIB) needs to develop reference standard Amb a 1-specific capture and biotin-labeled detection monoclonal aptamers suitable for use in Enzyme Linked Immunosorbent Assay (ELISA)/ImmunoEnzymetric Assay (IEMA) to measure biological potencies of commercial ragweed pollen extracts marketed in the United States. Scope Amb a 1-specific capture and biotin-labeled detection monoclonal antibodies suitable for use in Enzyme Linked Immunosorbent Assay (ELISA)/ImmunoEnzymetric Assay (IEMA).

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

Recipient
Aptagen LLC
UEI
HEK9BF17MKL3
CAGE
436H7
Vendor location
Jacobus, PA
Contract
75F40124P00523, purchase order
Obligated
$100,000.00
Actions
2 between September 27, 2024 and September 22, 2025
Competition
Competed Under SAP, 3 offers received
Set-aside reported
No Set Aside Used.
Described as
The Center for Biologics Evaluation and Research (Cber) Purchase Order for Dbpap/ Amb a 1-Specific Aptamers.
Match
solicitation number 75F40124Q00548 equals the FPDS solicitation identifier; same awarding office 75F401 (high confidence)
Record
USAspending award page

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. September 19, 2024

    Solicitation

    Due September 26, 2024 at 2:00 PM EDT. SAM.gov, notice f629c2ee7e9e49769976bf57c26ec2dc

  2. September 25, 2024

    Solicitation

    Due September 27, 2024 at 12:00 PM EDT. SAM.gov, notice 6f6bce7e8f58444b8332c459b3df41bd

  3. September 25, 2024

    Solicitation

    Due September 27, 2024 at 12:00 PM EDT. SAM.gov, notice d56340726c714a0194e1707063a30f69

Points of contact